Mounting evidence suggests that SIRT1, a class III NAD-dependent deacetylase, plays diverse roles in a number of cardiovascular and metabolic diseases including NASH [7]. Here, SIRT1 is linked to metabolic dysfunction-associated steatohepatitis.